A heterogeneity in SARS-CoV-2-specific CD4+ T-cell responses has been observed, concomitantly to the reported heterogeneity in clinical outcomes of the infection [12], as CD4+ T-cell frequencies are influenced by older age and comorbidities [28], while gender has no effect on CD4+ T-cell responses [12,13]. This evidence concerns the gene CD4 and infection.